Editorial no. 13

Gene editing is not only a scientific tool but also a mirror that reflects our ability to shape the future of humanity.

- Elon Musk

Recoding the Human Being: The Modification of the Impossible

Being able to combat a wide variety of genetic disorders that were thought to be incurable and even detect abnormalities in the DNA of a human fetus for future correction is undoubtedly a motivation that has driven innovation and the development of gene therapies around the world. Nonetheless, it is a modern and ever-evolving science that deserves the entire industry’s attention.

In this sense, preventing disease before it occurs is the ideal of any health system; however, giving life to a new gene therapy implies a high degree of investment and research in the field, together with experience in manufacturing and analyzing this type of medical advances. Those who have advanced on the path of genetic modification to provide greater certainty face a complex field full of obstacles, from developing new processes and manufacturing innovative medicines to complying with meticulous regulations to deliver safety and efficacy data, all within pressing deadlines.

All these efforts undoubtedly aim to improve the quality of human life. These advances represent a revolution in how we approach disease, attacking the genetic root of disorders and providing more precise and personalized solutions.

Drug discovery never stops; there is always more to explore and understand. There are currently patients with little or no treatment available for their condition, so it is essential to establish alliances with technology partners and contract development and manufacturing organizations to push science further by continuously innovating and optimizing to remain at the forefront of drug research and development.

Fortunately, each genetic modification is a small step toward a future where hereditary diseases are relics of the paast, and health is a choice rather than a destiny.

Carolina Villanuva, Editor in Chief